A new vaccine approach to HIV that stimulates a set of rare immune cells showed 97% success at targeting those cells in its first tests in humans.
from Livescience.com https://ift.tt/3cVOGSg
via IFTTT
world and global knowledge that you should know
0 komentar:
Posting Komentar